A genome-wide view of the de-differentiation of central nervous system endothelial cells in culture.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31913116.
- Also identified by DOI 10.7554/eLife.51276 and PMC identifier 6948952.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Vascular endothelial cells (ECs) derived from the central nervous system (CNS) variably lose their unique barrier properties during in vitro culture, hindering the development of robust assays for blood-brain barrier (BBB) function, including drug permeability and extrusion assays. In previous work (Sabbagh et al., 2018) we characterized transcriptional and accessible chromatin landscapes of acutely isolated mouse CNS ECs. In this report, we compare transcriptional and accessible chromatin landscapes of acutely isolated mouse CNS ECs versus mouse CNS ECs in short-term in vitro culture. We observe that standard culture conditions are associated with a rapid and selective loss of BBB transcripts and chromatin features, as well as a greatly reduced level of beta-catenin signaling. Interestingly, forced expression of a stabilized derivative of beta-catenin, which in vivo leads to a partial conversion of non-BBB CNS ECs to a BBB-like state, has little or no effect on gene expression or chromatin accessibility in vitro.
Medical subject headings
- Blood-Brain Barrier
- Cell Differentiation
- Central Nervous System
- Chromatin
- Endothelial Cells
- Transcription, Genetic
- beta Catenin